130 related articles for article (PubMed ID: 12117039)
1. Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax.
Zeng XM; O'Leary D; Phelan M; Jones S; Colledge J
Respir Med; 2002 Jun; 96(6):404-11. PubMed ID: 12117039
[TBL] [Abstract][Full Text] [Related]
2. Delivery of formoterol from a novel multi-dose inhaler Airmax.
Zeng XM; Jones S; O'Leary D; Phelan M; Colledge J
Respir Med; 2002 Jun; 96(6):397-403. PubMed ID: 12117038
[TBL] [Abstract][Full Text] [Related]
3. Lung deposition of budesonide from the novel dry powder inhaler Airmax.
Hirst RH; Newman SR; Clark DA; Hertog MG
Respir Med; 2002 Jun; 96(6):389-96. PubMed ID: 12117037
[TBL] [Abstract][Full Text] [Related]
4. Airmax: a multi-dose dry powder inhaler.
Keating GM; Faulds D
Drugs; 2002; 62(13):1887-95; discussion 1896-7. PubMed ID: 12215059
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
Pharmazie; 2004 Sep; 59(9):692-9. PubMed ID: 15497751
[TBL] [Abstract][Full Text] [Related]
6. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
Bisgaard H; Klug B; Sumby BS; Burnell PK
Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964
[TBL] [Abstract][Full Text] [Related]
7. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
8. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
[TBL] [Abstract][Full Text] [Related]
9. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
10. Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
Raula J; Rahikkala A; Halkola T; Pessi J; Peltonen L; Hirvonen J; Järvinen K; Laaksonen T; Kauppinen EI
Int J Pharm; 2013 Jan; 441(1-2):248-54. PubMed ID: 23200957
[TBL] [Abstract][Full Text] [Related]
11. A dry powder inhaler with reduced mouth-throat deposition.
Wang ZL; Grgic B; Finlay WH
J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
[TBL] [Abstract][Full Text] [Related]
13. Novolizer: a multidose dry powder inhaler.
Fenton C; Keating GM; Plosker GL
Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
[TBL] [Abstract][Full Text] [Related]
14. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
Tarsin W; Assi KH; Chrystyn H
J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
[TBL] [Abstract][Full Text] [Related]
15. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
[TBL] [Abstract][Full Text] [Related]
16. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
[TBL] [Abstract][Full Text] [Related]
17. Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax).
Dubois EF; Röder E; Iflé RG
Respir Med; 2003 Jan; 97(1):71-4. PubMed ID: 12556014
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
Ross DL; Schultz RK
J Aerosol Med; 1996; 9(2):215-26. PubMed ID: 10163351
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nebulizer performance under various humidity conditions.
Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
[TBL] [Abstract][Full Text] [Related]
20. Delivered Lung Dose and Aerodynamic Particle Size Distribution of Salbutamol Pressurized Metered Dose Inhaler After Living Under Patients' Realistic Retention Environments.
Ammari WG; Khalil Mohammad M; Tayyem RF; Martin GP; Royall PG
J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):386-395. PubMed ID: 31199708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
